About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

WITHDRAWNNANCT05829135

Improving Glare and Visual Comfort for Patients With Visual Impairment

To assess the use of contact lenses with transitions technology to improve glare, light sensitivity and overall visual comfort in patients with visual impairment.

Lead sponsor: Nova Southeastern University•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Nova Southeastern University

Collaborators

American Academy of Optometry

Acuvue Oasys Contact Lenses with Transitions Light Intelligent Technology can adapt to the amount of visible light in the environment, darkening the lenses in bright sunlight, and returning to regular tint in normal or dim environment. Purpose of this study is to assess whether individuals with visual impairment may benefit from these lenses to minimize glare, light sensitivity symptoms and improve the overall visual comfort.

Age

18 - 64 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Ability to give informed consent
•Able to speak and read English
•Experience glare and light sensitivity that impacts patient's daily living activities
•Have confirmed diagnosis of ocular condition including but not limited to Stargardt's, Cone dystrophy, Cone-rod dystrophy, Albinism, Retinitis Pigmentosa and Achromatopsia.
•Willing and able to wear the contact lenses as instructed

Exclusion Criteria

•Are pregnant, nursing or planning to become pregnant during the course of the study
•Have current/recent ocular infection, inflammation, surgery in the past 3 months that contraindicates contact lens wear

Related studies

Light Exposure, Migraine Outcomes, and Sleep Quality

NCT07476053 · Migraine Headache, Sleep, and more

Evaluation of Serum- and OCT Biomarkers in Patients With DME Treated With Anti-VEGF or Dexamethasone Implant

NCT06984822 · Diabetic Macular Edema, Visual Impairment, and more

Assessing the Impact of eSight Go At-Home Usage in Individuals With Visual Impairment

NCT07149259 · Low Vision Aids

In-person and Telehealth Visual Rehabilitation for Children With Low Vision

NCT06701617 · Visual Rehabilitation, Oddball Design, and more

Validation of a Parental Questionnaire for Screening Children for Neurovisual Disorders

NCT06997354 · Children Suffering From Cortical Visual Impairment

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 19, 2025Terms

Trial snapshot

StatusWITHDRAWN

PhaseNA

Enrollment—

Start dateMay 2023

Last updatedJun 19, 2025

Condition

Photophobia Visual Impairment Low Vision

Locations shown

Nova Southeastern University

Davie, Florida

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 19, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions